Correlation Between Corline Biomedical and Leading Edge

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corline Biomedical and Leading Edge at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corline Biomedical and Leading Edge into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corline Biomedical AB and Leading Edge Materials, you can compare the effects of market volatilities on Corline Biomedical and Leading Edge and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corline Biomedical with a short position of Leading Edge. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corline Biomedical and Leading Edge.

Diversification Opportunities for Corline Biomedical and Leading Edge

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Corline and Leading is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Corline Biomedical AB and Leading Edge Materials in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Leading Edge Materials and Corline Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corline Biomedical AB are associated (or correlated) with Leading Edge. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Leading Edge Materials has no effect on the direction of Corline Biomedical i.e., Corline Biomedical and Leading Edge go up and down completely randomly.

Pair Corralation between Corline Biomedical and Leading Edge

Assuming the 90 days trading horizon Corline Biomedical AB is expected to generate 0.82 times more return on investment than Leading Edge. However, Corline Biomedical AB is 1.22 times less risky than Leading Edge. It trades about 0.02 of its potential returns per unit of risk. Leading Edge Materials is currently generating about -0.02 per unit of risk. If you would invest  950.00  in Corline Biomedical AB on October 10, 2024 and sell it today you would earn a total of  20.00  from holding Corline Biomedical AB or generate 2.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Corline Biomedical AB  vs.  Leading Edge Materials

 Performance 
       Timeline  
Corline Biomedical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Corline Biomedical AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Corline Biomedical unveiled solid returns over the last few months and may actually be approaching a breakup point.
Leading Edge Materials 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Leading Edge Materials has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Corline Biomedical and Leading Edge Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corline Biomedical and Leading Edge

The main advantage of trading using opposite Corline Biomedical and Leading Edge positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corline Biomedical position performs unexpectedly, Leading Edge can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leading Edge will offset losses from the drop in Leading Edge's long position.
The idea behind Corline Biomedical AB and Leading Edge Materials pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon